Published in PLoS One on February 06, 2015
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Signatures of mutational processes in human cancer. Nature (2013) 21.63
Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell (2009) 5.74
Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell (2012) 4.58
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat Med (2007) 3.70
Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity (2008) 3.64
Functional hierarchy and reversibility within the murine spermatogenic stem cell compartment. Science (2010) 3.33
Airway basal stem cells: a perspective on their roles in epithelial homeostasis and remodeling. Dis Model Mech (2010) 3.17
Constitutive expression of AID leads to tumorigenesis. J Exp Med (2003) 3.16
AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science (2002) 3.09
Distal airway stem cells yield alveoli in vitro and during lung regeneration following H1N1 influenza infection. Cell (2011) 3.00
Dedifferentiation of committed epithelial cells into stem cells in vivo. Nature (2013) 2.85
DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. Elife (2013) 2.67
K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res (1996) 2.29
Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation. Nature (2012) 2.18
Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ (2005) 1.93
Muc-5/5ac mucin messenger RNA and protein expression is a marker of goblet cell metaplasia in murine airways. Am J Respir Cell Mol Biol (2000) 1.86
Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination. Nat Immunol (2010) 1.62
Cytodifferentiation of atypical adenomatous hyperplasia and bronchioloalveolar lung carcinoma: immunohistochemical and ultrastructural studies. Virchows Arch (1997) 1.47
Airway goblet cells: responsive and adaptable front-line defenders. Eur Respir J (1994) 1.41
Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G. PLoS One (2009) 1.39
Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers. Gastroenterology (2008) 1.37
European cancer mortality predictions for the year 2011. Ann Oncol (2011) 1.35
Cell cycle kinetics in the alveolar epithelium. Am J Physiol (1997) 1.34
Pathogenesis of mucous cell metaplasia in a murine asthma model. Am J Pathol (2003) 1.33
Negative regulation of activation-induced cytidine deaminase in B cells. Proc Natl Acad Sci U S A (2006) 1.30
Previous lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer Consortium. Am J Epidemiol (2012) 1.27
A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations. Oncogene (2008) 1.26
Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas. J Pathol (2007) 1.15
The pattern of K-ras mutation in pulmonary adenocarcinoma defines a new pathway of tumour development in the human lung. J Pathol (1997) 1.12
CELL TURNOVER IN THE RESPIRATORY TRACT. Dis Chest (1964) 1.10
Regulation of human lung alveolar multipotent cells by a novel p38α MAPK/miR-17-92 axis. EMBO J (2012) 1.09
Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. Lung Cancer (2005) 1.06
Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression. Int J Cancer (2008) 1.04
Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis. Int J Cancer (2007) 1.03
Single-stranded DNA structure and positional context of the target cytidine determine the enzymatic efficiency of AID. Mol Cell Biol (2007) 1.01
Modelling mutational landscapes of human cancers in vitro. Sci Rep (2014) 0.99
p53 alterations in atypical alveolar hyperplasia of the human lung. Hum Pathol (1998) 0.95
Keratinocyte growth factor-induced hyperplasia of rat alveolar type II cells in vivo is resolved by differentiation into type I cells and by apoptosis. Eur Respir J (1999) 0.94
Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung. J Thorac Oncol (2010) 0.92
Aberrant expression and mutation-inducing activity of AID in human lung cancer. Ann Surg Oncol (2011) 0.88
Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung. Pathol Int (2000) 0.88
The dark side of activation-induced cytidine deaminase: relationship with leukemia and beyond. Int J Hematol (2006) 0.82